S. Soppe

发表

Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines

I. Barr, K. Laurie, C. Baas, 2021, NPJ vaccines.

In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection

S. Lewin, C. Thio, P. Revill, 2012, Journal of medical virology.

Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.

R. Hammond, P. Revill, N. Warner, 2021, Journal of hepatology.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021.

I. Barr, K. Subbarao, Ammar Aziz, 2020, Communicable diseases intelligence.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018.

I. Barr, Heidi Peck, A. Todd, 2020, Communicable diseases intelligence.

Characterization of Hepatitis B Precore/Core-Related Antigens

P. Revill, W. Delaney, B. Feierbach, 2020, Journal of Virology.

Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis.

N. Warner, S. Locarnini, S. Soppe, 2017, Virology.

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody.

O. Dolezal, P. Revill, S. Locarnini, 2011, Virology.

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

Domenico Di Carlo, F. Ceccherini‐Silberstein, H. Fleury, 2017, Oncotarget.

Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines

I. Barr, K. Laurie, C. Baas, 2021, npj Vaccines.

Communicable Diseases Intelligence Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020–2021

I. Barr, K. Subbarao, Ammar Aziz, 2022 .